PayerPrice
Data Platform
Who We Serve
Use Cases
More
Check Local Rates

HCPCS J9026 (Imdelltra) Fee Schedule

Last Verified: October 2026

Healthcare providers use this code to document and receive reimbursement for visits that address high-level medical decision-making, often including multiple diagnoses or prescription management.

Injection, tarlatamab-dlle, 1 mg
Key FactDetail
Service Type

Chemotherapy Drugs

Complexity LevelHigh
Medicaid Fee ScheduleView Medicaid rates for J9026
Medicare Payment Limit
$1564.636BuyandBill.com
WAC Price
Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur

National average reimbursement for HCPCS J9026 by major payers:

bcbs

$1,626.67

uhc

$1,571.80

aetna

$3,002.99

cigna

$1,530.00

Compare published rates across providers.

Choose a payer to see a sample of rates for HCPCS J9026.

HCPCS J9026
5 of 25 sample ratesHigher to lower in this preview
  1. Jessica Hayward

    CAGeneral Acute Care HospitalNPI 1598930075Tax ID 94-3281660

    $2,948.58Published rate
  2. Joshua Strauss

    NJHematology & Oncology PhysicianNPI 1699919597Tax ID 20-2088165

    $1,765.01Published rate
  3. Megan Mezera

    NJRadiation Oncology PhysicianNPI 1477865426Tax ID 23-2696460

    $1,633.91Published rate
  4. Minaxi Jhawer

    NJHematology & Oncology PhysicianNPI 1487760930Tax ID 45-2548322

    $1,545.00Published rate
  5. Ester Pollard

    Coastal Bend Oncology Hematology

    TXHematology & Oncology PhysicianNPI 1225002843Tax ID 42-1530203

    $1,313.25Published rate

National sample. Rates vary by location, specialty, and contract.

Get a free rate benchmark for your specialty.

Choose your state and specialty to build a report from payer-published rates.

Use market rates to prepare your payer proposal.

Rate Benchmarking

Compare your rates with similar providers.

Select a published rate, define comparable providers, and see where that rate falls in your market.

See a sample rate comparison

Payer Contract Negotiation

Draft a fee schedule renegotiation letter.

Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.

See a sample payer proposal

HCPCS J9026 vs. Other Chemotherapy Drugs Codes

The HCPCS J9026 code is part of the Chemotherapy Drugs services . It represents a moderate-complexity encounter and is one of several codes that vary based on time spent, level of medical decision-making, and documentation requirements.

The HCPCS J9026 code involves more provider time and moderate medical decision-making, unlike lower-level codes that require less time and simpler assessments. It typically includes multiple diagnoses, medication management, or test interpretation, leading to higher reimbursement and more detailed documentation requirements.

CodeComplexityDescription
J9026-HCPCSHighInjection, tarlatamab-dlle, 1 mg

What is a fee schedule?

A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J9026. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.

Understanding the J9026 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.

Factors that affect fee schedules


Medicare & Medicaid Rates

Government-set reimbursement amounts


Private Insurance Rates

Negotiated rates between providers and insurance companies


Geographic Location

Costs may be higher in urban areas.


Provider Type

Hospital providers may have different rates than private practice.

FREE SAMPLE MARKET COMPARISON

Let's review your payer contracts side-by-side with the market.

Bring your top codes (like HCPCS J9026) and we'll show you how you compare in 15 minutes or less.